leadf
logo-loader
viewAethlon Medical Inc

Aethlon Medical CEO says 'time is right' to move Aethlon Hemopurifier to human studies

Aethlon Medical Inc (NASDAQ:AEMD) CEO Jim Joyce spoke with Proactive Investor's Christine Corrado at the BIO Investor Forum in San Francisco.

The San Diego based company is focused on addressing unmet needs in global health and biodefense with the Aethlon Hemopurifier, a therapeutic device designed for the rapid depletion of circulating viruses and cancer promoting exosomes.

Quick facts: Aethlon Medical Inc

Price: 1.82 USD

NASDAQ:AEMD
Market: NASDAQ
Market Cap: $22 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

FansUnite Entertainment pleased Canada taking a look at allowing single...

FansUnite Entertainment (CSE: FANS- OTCQB: FUNFF) President Darius Eghdami joined Steve Darling from Proactive with news the company is hailing the Canadian government’s decision to introduce legislation that would legalize single-event sports betting in Canada. Eghdami talks about why that...

59 minutes ago

2 min read